Better Buy: Abbott Laboratories vs. DexCom
Published
These two companies are battling for market share of continuous glucose monitoring devices for diabetes, with each coming out with new models soon.
Full ArticlePublished
These two companies are battling for market share of continuous glucose monitoring devices for diabetes, with each coming out with new models soon.
Full ArticleThese stocks have been going in opposite directions of late.